|

duloxetine Clinical Trials

5 actively recruiting trials across 1 location

▼ -2 trials since August 2026

Also known as: Chemotherapy containing taxanes, Cymbalta, Irenka, duloxetine hydrochloride

Pipeline

Phase 2: 2Phase 4: 2Phase 1/2: 1

Top Sponsors

  • Yan Yang, MD, Ph.D1
  • Sunnybrook Health Sciences Centre1
  • Northwestern University1
  • Fudan University1
  • First Affiliated Hospital of Chongqing Medical University1

Indications

Other4 trials

ADC-induced Neurotoxicity Treated With Duloxetine
Phase 2
Effect of peRiopErative duLoxetIne Administration on Opioid Consumption Following Total kneE Arthroplasty (RELIFE)
Phase 4
Efficacy and Safety of Duloxetine in Chinese Solid Tumor Patients With Taxanes-induced Painful Peripheral Neuropathy
Phase 2
Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD)
Phase 1/2

Chicago, Illinois1 trial

Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis

Northwestern University

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.